BSEInsider Trading / SAST3d ago · 22 Sept 2026, 05:02 pm

Closure of Trading window

Dr Reddys Laboratories Ltd · 500124

✦ AI SummaryResults

Dr Reddys Laboratories Ltd has announced the closure of its trading window from September 24, 2026 to October 25, 2026, ahead of its board meeting on October 23, 2026 to consider unaudited financial results for the quarter ending September 30, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Dr Reddys Laboratories Ltd - 500124 - Closure of Trading Window

Attachments (1)

📄

a10b6800-dc29-49db-a910-41f090ac404c.pdf

pdf

Download →
View document text
Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills Hyderabad – 500 034, Telangana, India CIN: L85195TG1984PLC004507 Tel: + 91 40 4900 2900 Fax: + 91 40 4900 2999 Email: mail@drreddys.com Web: www.drreddys.com September 22, 2026 National Stock Exchange of India Ltd. (Scrip Code: DRREDDY) BSE Limited (Scrip Code: 500124) New York Stock Exchange Inc. (Stock Code: RDY) NSE IFSC Ltd. (Stock Code: DRREDDY) Dear Sir/Madam, Sub: Intimation regarding Board meeting and trading window closure Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that a meeting of the Board of Directors of the Company will be held on Friday, October 23, 2026, inter alia, to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ending on September 30, 2026. Further, kindly note that, under the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in securities of the Company will be closed from September 24, 2026 to October 25, 2026 (both days inclusive). This is for your information and records. Thanking you, Yours faithfully, For Dr. Reddy’s Laboratories Limited K Randhir Singh Company Secretary, Compliance Officer & Head-CSR